Topics

Chemistry
FDA forces UCLA researchers to stop touting experimental dementia scan
FDA forces UCLA researchers to stop touting experimental dementia scan

The federal government has forced two UCLA researchers to stop making promotional claims about an experimental brain scan they hope to commercialize as a test for Alzheimer’s disease, long-term damage from traumatic brain injuries and other neurological conditions. The website for their fledgling company, Taumark, suggested that injecting patients with FDDNP — an experimental, short-lived radioactive compound — and scanning their brains could offer early detection of concussions and various forms of dementia. The site featured photographs of football players, a soldier and an elderly couple. One caption read: “Protecting our athletes who want to know about the...

Loading